Biopharmaceutical leader in the development of treatments for rare diseases
Education about the value of innovative new medicines and the Orphan Drug Act.

H.R.195: Making further continuing appropriations for the fiscal year ending September 30, 2018, and for other purposes, as it relates to the HEALTHY KIDS Act CHIP reauthorization.

Reauthorization of the Animal Drug User Fee Act (ADUFA). 

Right to Try legislation.

H.R.4679: Ensuring Equal Access to Treatments Act of 2017. Education about reimbursement for orphan drug therapies in skilled nursing facilities and proposed add-on payments in inpatient hospitals.
HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX